Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Tramadol Retard GPO 100 mg vs Tramal Retard 100 mg under fasting conditions
TCTR20180308003Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tramadol in pain (2 arms), sponsored by Government Pharmaceutical Organization. Planned start May 2018; status: not yet recruiting.
02
Drugs
tramadol
03
Conditions
pain
Beyond the preview
Go deeper on TCTR20180308003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180308003.